Birla Fertility & IVF Bundle
Who Really Owns Birla Fertility & IVF?
Unraveling the ownership of Birla Fertility & IVF is key to understanding its ambitious expansion in the Indian IVF market. Established in 2020, this Birla Fertility & IVF SWOT Analysis company has quickly become a major player, fueled by strategic acquisitions and a vision for widespread fertility care. Understanding the ownership structure of Birla Fertility & IVF is crucial for investors and anyone tracking the healthcare sector.
The Birla Fertility & IVF story is one of rapid growth, backed by the influential CK Birla Group. This article will explore the ownership of Birla Fertility Company, from its founding to its current status, shedding light on the key players and their influence. Knowing who owns Birla IVF will help you understand the company's strategic direction and its commitment to expanding access to IVF services across India.
Who Founded Birla Fertility & IVF?
The establishment of Birla Fertility & IVF dates back to 2020, with Avanti Birla as the founder. As a part of the CK Birla Group, the company's ownership structure is primarily rooted within the group's framework. Avanti Birla's role as Chairman and Founder signals a significant leadership position from the outset.
Birla Fertility & IVF operates under CK Birla Healthcare Private Limited, incorporated on October 17, 2014, suggesting a strategic integration within the CK Birla Group's healthcare division. This structure highlights the group's commitment to expanding its healthcare ventures. The company's financial backing comes from the CK Birla Group, which provides the necessary capital for its operations and expansion.
The initial ownership details, including the equity split, are not publicly available. The company has not engaged in external funding rounds such as venture capital or private equity. The CK Birla Group's financial support is crucial for Birla Fertility & IVF's growth. The founding vision, as articulated by Avanti Birla, focuses on delivering quality, patient-centered care with a holistic approach to fertility treatment.
Founded in 2020 by Avanti Birla.
Birla Fertility & IVF is a part of the CK Birla Group.
Avanti Birla serves as the Chairman and Founder.
Operates under CK Birla Healthcare Private Limited.
Financially backed by the CK Birla Group.
Focus on quality, patient-centered care.
The ownership of Birla Fertility & IVF is primarily held within the CK Birla Group, with Avanti Birla playing a key role as the founder and chairman. The company's financial support comes directly from its parent group, ensuring its operational and expansion capabilities. While specific equity splits and early investor details are not publicly available, the focus remains on delivering quality healthcare services. For more insights into the company's operations, you can refer to this article about Birla Fertility & IVF.
- Avanti Birla is the Founder and Chairman.
- CK Birla Group provides financial backing.
- No external venture capital or private equity rounds.
- Operates under CK Birla Healthcare Private Limited.
Birla Fertility & IVF SWOT Analysis
- Complete SWOT Breakdown
- Fully Customizable
- Editable in Excel & Word
- Professional Formatting
- Investor-Ready Format
How Has Birla Fertility & IVF’s Ownership Changed Over Time?
The ownership evolution of Birla Fertility & IVF, often referred to as Birla IVF, is primarily shaped by strategic acquisitions. As part of the CK Birla Group, a privately held conglomerate, the ownership structure of Birla Fertility & IVF is concentrated within the group. This structure differs significantly from publicly listed companies, where ownership is distributed among shareholders. The focus has been on rapid expansion within the Indian fertility market through strategic acquisitions, making it a key player in the IVF Clinic sector.
Key acquisitions have significantly altered the operational footprint and market share of Birla Fertility & IVF. In May 2024, Birla Fertility & IVF acquired an 86% stake in ARMC IVF, a Kerala-based company, for an undisclosed amount, estimated to be under ₹100 crore. This added seven centers to its network, marking its entry into South India. Following this, in August 2024, Birla Fertility & IVF acquired a majority stake in BabyScience IVF, a Bangalore-based chain, for approximately Rs 100 crore. This brought 12 clinics under its management, further strengthening its presence in Karnataka, Maharashtra, and Tamil Nadu. These moves have propelled Birla Fertility & IVF to become a leading entity in the IVF sector.
| Acquisition | Date | Impact |
|---|---|---|
| ARMC IVF | May 2024 | Entry into South India, added 7 centers |
| BabyScience IVF | August 2024 | Strengthened presence in Karnataka, Maharashtra, and Tamil Nadu, added 12 clinics |
| Future Expansion Plans | By FY28 | Expansion to 100 clinics with an investment of over Rs 500 crore |
As of August 2024, Birla Fertility & IVF had become India's third-largest IVF chain, managing 50 clinics nationwide, and 51 clinics as of June 2025. The CK Birla Group, with Avanti Birla as the Chairman and Founder, and Akshat Seth as Vice Chairman of CK Birla Healthcare, remains the major stakeholder. The company's strategic direction and expansion are overseen by the CK Birla Group, with plans to invest over Rs 500 crore to expand to 100 clinics by FY28. For more insights into the target market, consider reading Target Market of Birla Fertility & IVF.
Birla Fertility & IVF is owned by the CK Birla Group, focusing on expansion through strategic acquisitions.
- Acquired ARMC IVF in May 2024.
- Acquired BabyScience IVF in August 2024.
- Plans to expand to 100 clinics by FY28.
- The company is a leading IVF Clinic in India.
Birla Fertility & IVF PESTLE Analysis
- Covers All 6 PESTLE Categories
- No Research Needed – Save Hours of Work
- Built by Experts, Trusted by Consultants
- Instant Download, Ready to Use
- 100% Editable, Fully Customizable
Who Sits on Birla Fertility & IVF’s Board?
As a subsidiary of the privately held CK Birla Group, the Birla Fertility & IVF (Birla IVF) company's governance structure differs from that of a publicly traded entity. The board of directors and strategic oversight are integrated within the broader CK Birla Healthcare framework, which is part of the CK Birla Group. This structure means that the specific details of a traditional board of directors, as seen in public companies, are not directly applicable.
The key leadership roles within Birla Fertility & IVF include Avanti Birla, who serves as the Chairman and Founder, providing significant leadership. Abhishek Aggrawal is the Chief Business Officer and also holds a CEO position. Akshat Seth serves as the Vice Chairman of C K Birla Healthcare, the parent entity. These individuals are central to decision-making, aligning the strategies of Birla Fertility & IVF with the overall objectives of the CK Birla Group.
| Leadership Role | Name | Title |
|---|---|---|
| Chairman and Founder | Avanti Birla | Chairman |
| Chief Business Officer & CEO | Abhishek Aggrawal | CEO |
| Vice Chairman | Akshat Seth | Vice Chairman of C K Birla Healthcare |
Due to its private ownership, specific details on voting rights, such as dual-class shares or founder shares, are not publicly disclosed. Control is centralized within the CK Birla Group, which dictates strategic direction and financial allocations for Birla Fertility & IVF. There have been no publicly reported proxy battles or governance controversies, reflecting an integrated operational model. The decision-making process is driven by the group's business objectives and long-term vision. For more insights, consider exploring the Marketing Strategy of Birla Fertility & IVF.
Birla Fertility & IVF operates under the CK Birla Group's umbrella, with Avanti Birla as Chairman and Founder. Abhishek Aggrawal serves as CEO, and Akshat Seth as Vice Chairman of the parent entity.
- Private ownership structure.
- Centralized control within the CK Birla Group.
- No publicly reported governance controversies.
Birla Fertility & IVF Business Model Canvas
- Complete 9-Block Business Model Canvas
- Effortlessly Communicate Your Business Strategy
- Investor-Ready BMC Format
- 100% Editable and Customizable
- Clear and Structured Layout
What Recent Changes Have Shaped Birla Fertility & IVF’s Ownership Landscape?
Over the past few years, Birla Fertility & IVF has actively expanded, primarily through acquisitions and significant investments from its parent company, the CK Birla Group. The company's aggressive growth strategy includes a commitment to invest over Rs 500 crore to expand its network, aiming for 100 clinics by FY28. This rapid expansion has reshaped the ownership landscape and market position of Birla Fertility & IVF.
Recent acquisitions have been pivotal to this growth. In May 2024, Birla Fertility & IVF acquired an 86% stake in ARMC IVF, and in August 2024, it acquired a majority stake in BabyScience IVF. As of June 2025, these moves have positioned Birla Fertility & IVF as India's third-largest fertility chain, operating 51 clinics across 38 cities and 18 states. This expansion is a direct reflection of the ownership's strategic vision to dominate the Indian fertility market.
| Key Aspect | Details | Impact |
|---|---|---|
| Acquisitions | ARMC IVF (May 2024), BabyScience IVF (August 2024) | Increased market share, expanded clinic network |
| Expansion Strategy | Focus on Tier II and III cities (approx. 60% of current footprint) | Addresses unmet demand, strategic market penetration |
| Leadership | Avanti Birla (Chairman & Founder), Abhishek Aggrawal (CEO) | Ensures continuity and drives growth |
| Financial Performance (FY23) | Net Sales: Rs 218 crore, Losses: Rs 61 crore | Reflects investment in growth and expansion |
The Indian IVF market, valued at approximately $700 million in 2024, is projected to reach $1.45 billion by 2027 and potentially exceed $5.05 billion by 2033. This growth is fueled by rising infertility rates and advancements in assisted reproductive technologies, aligning perfectly with Birla Fertility & IVF's expansion strategy. The company's focus on Tier II and III cities is a strategic move to capture a larger share of the growing demand for fertility treatments. The company's growth strategy is well-detailed in Growth Strategy of Birla Fertility & IVF.
The CK Birla Group is the parent company and primary owner of Birla Fertility & IVF.
The company is privately held, with ownership concentrated within the CK Birla Group.
No, Birla Fertility & IVF is not a publicly listed company.
Avanti Birla founded Birla Fertility & IVF and continues to serve as the Chairman.
Birla Fertility & IVF Porter's Five Forces Analysis
- Covers All 5 Competitive Forces in Detail
- Structured for Consultants, Students, and Founders
- 100% Editable in Microsoft Word & Excel
- Instant Digital Download – Use Immediately
- Compatible with Mac & PC – Fully Unlocked
Related Blogs
- What are Mission Vision & Core Values of Birla Fertility & IVF Company?
- What is Competitive Landscape of Birla Fertility & IVF Company?
- What is Growth Strategy and Future Prospects of Birla Fertility & IVF Company?
- How Does Birla Fertility & IVF Company Work?
- What is Sales and Marketing Strategy of Birla Fertility & IVF Company?
- What is Brief History of Birla Fertility & IVF Company?
- What is Customer Demographics and Target Market of Birla Fertility & IVF Company?
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.